These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 35685992)

  • 21. Multimarker gene analysis of circulating tumor cells in pancreatic cancer patients: a feasibility study.
    de Albuquerque A; Kubisch I; Breier G; Stamminger G; Fersis N; Eichler A; Kaul S; Stölzel U
    Oncology; 2012; 82(1):3-10. PubMed ID: 22270149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytokeratin-20 and Survivin-Expressing Circulating Tumor Cells Predict Survival in Metastatic Colorectal Cancer Patients by a Combined Immunomagnetic qRT-PCR Approach.
    Ning Y; Hanna DL; Zhang W; Mendez A; Yang D; El-Khoueiry R; Matsusaka S; Sunakawa Y; Stremitzer S; Parekh A; Okazaki S; Berger MD; Barzi A; Lenz HJ
    Mol Cancer Ther; 2015 Oct; 14(10):2401-8. PubMed ID: 26227487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dual-Aptamer-Targeted Immunomagnetic Nanoparticles to Accurately Explore the Correlations between Circulating Tumor Cells and Gastric Cancer.
    Li C; Yang S; Li R; Gong S; Huang M; Sun Y; Xiong G; Wu D; Ji M; Chen Y; Gao C; Yu Y
    ACS Appl Mater Interfaces; 2022 Feb; 14(6):7646-7658. PubMed ID: 35104098
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial-mesenchymal transition markers in the first-line chemotherapy of HER2-negative metastatic breast cancer.
    Guan X; Ma F; Li C; Wu S; Hu S; Huang J; Sun X; Wang J; Luo Y; Cai R; Fan Y; Li Q; Chen S; Zhang P; Li Q; Xu B
    Cancer Commun (Lond); 2019 Jan; 39(1):1. PubMed ID: 30606259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictive value of circulating tumor cells (CTCs) in newly-diagnosed and recurrent ovarian cancer patients.
    Liu JF; Kindelberger D; Doyle C; Lowe A; Barry WT; Matulonis UA
    Gynecol Oncol; 2013 Nov; 131(2):352-6. PubMed ID: 23954902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Plasticity of Circulating Tumor Cells in Ovarian Cancer During Platinum-containing Chemotherapy.
    Gening SO; Dolgova DR; Abakumova TV; Antoneeva II; Gening TP
    Curr Cancer Drug Targets; 2021; 21(11):965-974. PubMed ID: 34288839
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sensitive detection of viable circulating tumor cells using a novel conditionally telomerase-selective replicating adenovirus in non-small cell lung cancer patients.
    Togo S; Katagiri N; Namba Y; Tulafu M; Nagahama K; Kadoya K; Takamochi K; Oh S; Suzuki K; Sakurai F; Mizuguchi H; Urata Y; Takahashi K
    Oncotarget; 2017 May; 8(21):34884-34895. PubMed ID: 28432274
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of circulating tumour cells in patients with epithelial ovarian cancer by a microfluidic system.
    Rao Q; Zhang Q; Zheng C; Dai W; Zhang B; Ionescu-Zanetti C; Lin Z; Zhang L
    Int J Clin Exp Pathol; 2017; 10(9):9599-9606. PubMed ID: 31966837
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating tumor cells (CTCs) detected by triple-marker EpCAM, CK19, and hMAM RT-PCR and their relation to clinical outcome in metastatic breast cancer patients.
    Zhao S; Yang H; Zhang M; Zhang D; Liu Y; Liu Y; Song Y; Zhang X; Li H; Ma W; Zhang Q
    Cell Biochem Biophys; 2013 Mar; 65(2):263-73. PubMed ID: 22990361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical significance of EpCAM mRNA-positive circulating tumor cells in hepatocellular carcinoma by an optimized negative enrichment and qRT-PCR-based platform.
    Guo W; Yang XR; Sun YF; Shen MN; Ma XL; Wu J; Zhang CY; Zhou Y; Xu Y; Hu B; Zhang X; Zhou J; Fan J
    Clin Cancer Res; 2014 Sep; 20(18):4794-805. PubMed ID: 25009297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating Tumor Cell Detection In Epithelial Ovarian Cancer Using Dual-Component Antibodies Targeting EpCAM And FRα.
    Li N; Zuo H; Chen L; Liu H; Zhou J; Yao Y; Xu B; Gong H; Weng Y; Hu Q; Song Q; Peng M; Cheng Y
    Cancer Manag Res; 2019; 11():10939-10948. PubMed ID: 32021417
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of circulating tumor cell (CTC) detection rates with epithelial cell adhesion molecule (EpCAM) and cell surface vimentin (CSV) antibodies in different solid tumors: a retrospective study.
    Gao Y; Fan WH; Song Z; Lou H; Kang X
    PeerJ; 2021; 9():e10777. PubMed ID: 33717672
    [TBL] [Abstract][Full Text] [Related]  

  • 33. EMT-like circulating tumor cells in ovarian cancer patients are enriched by platinum-based chemotherapy.
    Chebouti I; Kasimir-Bauer S; Buderath P; Wimberger P; Hauch S; Kimmig R; Kuhlmann JD
    Oncotarget; 2017 Jul; 8(30):48820-48831. PubMed ID: 28415744
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating stem cell-like epithelial cell adhesion molecule-positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection.
    Sun YF; Xu Y; Yang XR; Guo W; Zhang X; Qiu SJ; Shi RY; Hu B; Zhou J; Fan J
    Hepatology; 2013 Apr; 57(4):1458-68. PubMed ID: 23175471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ERCC1-expressing circulating tumor cells as a potential diagnostic tool for monitoring response to platinum-based chemotherapy and for predicting post-therapeutic outcome of ovarian cancer.
    Chebouti I; Kuhlmann JD; Buderath P; Weber S; Wimberger P; Bokeloh Y; Hauch S; Kimmig R; Kasimir-Bauer S
    Oncotarget; 2017 Apr; 8(15):24303-24313. PubMed ID: 28388557
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictive value of circulating tumor cells (CTCs) captured by microfluidic device in patients with epithelial ovarian cancer.
    Lee M; Kim EJ; Cho Y; Kim S; Chung HH; Park NH; Song YS
    Gynecol Oncol; 2017 May; 145(2):361-365. PubMed ID: 28274569
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of Preoperative NANOG-Positive Circulating Tumor Cell Levels With Recurrence of Hepatocellular Carcinoma.
    Lei Y; Wang X; Sun H; Fu Y; Tian Y; Yang L; Wang J; Xia F
    Front Oncol; 2021; 11():601668. PubMed ID: 34123777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of Cell Surface Vimentin Positive Circulating Tumor Cells as a Diagnostic Biomarker for Lung Cancer.
    Xie X; Wang L; Wang X; Fan WH; Qin Y; Lin X; Xie Z; Liu M; Ouyang M; Li S; Zhou C
    Front Oncol; 2021; 11():672687. PubMed ID: 34055642
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficient isolation and quantification of circulating tumor cells in non-small cell lung cancer patients using peptide-functionalized magnetic nanoparticles.
    Liang N; Liu L; Li P; Xu Y; Hou Y; Peng J; Song Y; Bing Z; Wang Y; Wang Y; Jia Z; Yang X; Li D; Xu H; Yu Q; Li S; Hu Z; Yang Y
    J Thorac Dis; 2020 Aug; 12(8):4262-4273. PubMed ID: 32944338
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of circulating tumor cell-specific markers in breast cancer patients using the quantitative RT-PCR assay.
    Wang HY; Ahn S; Kim S; Park S; Jung D; Park S; Han H; Sohn J; Kim S; Lee H
    Int J Clin Oncol; 2015 Oct; 20(5):878-90. PubMed ID: 25708591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.